A Glu-urea-Lys Ligand-conjugated Lipid Nanoparticle/siRNA System Inhibits Androgen Receptor Expression In Vivo
The androgen receptor plays a critical role in the progression of prostate cancer. Here, we describe targeting the prostate-specific membrane antigen using a lipid nanoparticle formulation containing small interfering RNA designed to silence expression of the messenger RNA encoding the androgen rece...
Saved in:
Main Authors: | Justin B Lee (Author), Kaixin Zhang (Author), Yuen Yi C Tam (Author), Joslyn Quick (Author), Ying K Tam (Author), Paulo JC Lin (Author), Sam Chen (Author), Yan Liu (Author), Jayaprakash K Nair (Author), Ivan Zlatev (Author), Kallanthottathil G Rajeev (Author), Muthiah Manoharan (Author), Paul S Rennie (Author), Pieter R Cullis (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles
by: Barbara L Mui, et al.
Published: (2013) -
Advances in Lipid Nanoparticles for siRNA Delivery
by: Sam Chen, et al.
Published: (2013) -
Synthesis of an Al18F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand in an automated synthesis platform
by: Javier Giglio, et al.
Published: (2018) -
Glu-Urea-Lys Scaffold Functionalized Superparamagnetic Iron Oxide Nanoparticles Targeting PSMA for In Vivo Molecular MRI of Prostate Cancer
by: Wei Zhou, et al.
Published: (2022) -
MMP-8 C-799 T, Lys460Thr, and Lys87Glu variants are not related to risk of cancer
by: Li-Feng Zhang, et al.
Published: (2019)